http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943327-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c1dae008baa5e165bff1b8a6178aafa7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-101666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-7158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70514
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-94
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
filingDate 2007-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bad0ac6744344b5143ccab35759f19d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50dc2f65095af18369efec88352a9139
publicationDate 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7943327-B2
titleOfInvention Simultaneous assay of target and target-drug binding
abstract Whole cell, simultaneous target and drug-target assay using differentially labeled antibodies and flow cytometry. First antibody binds to total target and second antibody binds to the drug binding site of the target, thus drug binding will competitively inhibit the second antibody allowing for a competitive inhibition assay of drug-target binding. The assay allows for whole cell analysis and even analysis of mixed populations of cells, yet provides detailed kinetic assessment of drug activity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014242610-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9535065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011212469-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8389224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8828671-B2
priorityDate 2004-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5599677-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7326577-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003133936-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5597688-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6579687-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57300161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136284721
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399456

Total number of triples: 45.